KRAS and pancreatic neoplasm: To assess whether the expression of Dab2 is linked to a specific mutational profile, mRNA and protein levels were determined in a panel of pancreatic cancer cell lines whose mutational status of KRAS, INK4A, TP53, and SMAD4 has been previously determined (Table S1)34–36.